In breast tumors, Winter et al. (200) discovered that the decrease in expression of PER1 in familial breast cancer is particularly significant, and the low expression of PER1 is related to negative estrogen receptor (ER) levels, which make hormone therapy drugs ineffective. Here, ESR1 is linked to breast neoplasm.